These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
619 related items for PubMed ID: 29056067
1. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance. Mori T, Kuzumaki N, Arima T, Narita M, Tateishi R, Kondo T, Hamada Y, Kuwata H, Kawata M, Yamazaki M, Sugita K, Matsuzawa A, Baba K, Yamauchi T, Higashiyama K, Nonaka M, Miyano K, Uezono Y, Narita M. Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067 [Abstract] [Full Text] [Related]
4. Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia. Muchhala KH, Jacob JC, Dewey WL, Akbarali HI. Eur J Pharmacol; 2021 May 15; 899():174007. PubMed ID: 33705801 [Abstract] [Full Text] [Related]
5. A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. DeWire SM, Yamashita DS, Rominger DH, Liu G, Cowan CL, Graczyk TM, Chen XT, Pitis PM, Gotchev D, Yuan C, Koblish M, Lark MW, Violin JD. J Pharmacol Exp Ther; 2013 Mar 15; 344(3):708-17. PubMed ID: 23300227 [Abstract] [Full Text] [Related]
6. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats. Schwienteck KL, Faunce KE, Rice KC, Obeng S, Zhang Y, Blough BE, Grim TW, Negus SS, Banks ML. Neuropharmacology; 2019 May 15; 150():200-209. PubMed ID: 30660628 [Abstract] [Full Text] [Related]
7. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH2, a mu opioid receptor agonist biased toward β-arrestin. Gach-Janczak K, Piekielna-Ciesielska J, Adamska-Bartłomiejczyk A, Wtorek K, Ferrari F, Calo' G, Szymaszkiewicz A, Piasecka-Zelga J, Janecka A. Peptides; 2018 Jul 15; 105():51-57. PubMed ID: 29684591 [Abstract] [Full Text] [Related]
8. Further investigation of the rapid-onset and short-duration action of the G protein-biased μ-ligand oliceridine. Mori T, Takemura Y, Arima T, Iwase Y, Narita M, Miyano K, Hamada Y, Suda Y, Matsuzawa A, Sugita K, Matsumura S, Sasaki S, Yamauchi T, Higashiyama K, Uezono Y, Yamazaki M, Kuzumaki N, Narita M. Biochem Biophys Res Commun; 2021 Jan 01; 534():988-994. PubMed ID: 33139013 [Abstract] [Full Text] [Related]
9. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. Nature; 2000 Dec 07; 408(6813):720-3. PubMed ID: 11130073 [Abstract] [Full Text] [Related]
13. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2. Ozaki S, Narita M, Narita M, Iino M, Miyoshi K, Suzuki T. Neuroscience; 2003 Dec 07; 116(1):89-97. PubMed ID: 12535942 [Abstract] [Full Text] [Related]
15. Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine. Mizobuchi Y, Miyano K, Manabe S, Uezono E, Komatsu A, Kuroda Y, Nonaka M, Matsuoka Y, Sato T, Uezono Y, Morimatsu H. Biomolecules; 2022 Mar 10; 12(3):. PubMed ID: 35327617 [Abstract] [Full Text] [Related]
19. Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist. Doi S, Mori T, Uzawa N, Arima T, Takahashi T, Uchida M, Yawata A, Narita M, Uezono Y, Suzuki T, Narita M. Mol Pain; 2016 Mar 10; 12():. PubMed ID: 27317580 [Abstract] [Full Text] [Related]